The purpose of this IMDRF guidance is to harmonize the documentation and procedures that are 60 used to assess whether a medical device conforms to the regulations that apply in each jurisdiction. The worldwide adoption of fundamental design and manufacturing requirements for medical devices that, when met, provide assurance the device is safe and performs as intended, offers significant benefits to the manufacturer, user, patient or consumer, and to Regulatory Authorities. Eliminating differences between jurisdictions decreases the cost of gaining regulatory compliance and allows patients earlier access to new technologies and treatments.
News & Trends
Procurar
Recentes
- EMA guidance on Electronic product information (ePI) submission during centralised procedures
- EU Medical Device Regulation (2017/745) and In Vitro Diagnostic Medical Device Regulation (2017/746) – Impact on international registrations. Middle East and Africa focus
- IMDRF Document Implementation Report. 1 September 2026
- EU Regulatory News : IVD Classification Rules – MDCG 2020-16 Rev.5
- Revised version of EU GMP Annex 19: Reference and Retention Samples
- Evaluation of Therapeutic Equivalence. Guidance for Industry
- FDA Considerations for the Regulation of Generative Al-Enabled Medical Devices: Discussion Paper and Request for Feedback
- EMA Guidance for industry on implementing Shortage Prevention Plans (SPP)

